SXTC (China SXT Pharmaceuticals) 1-Year Share Buyback Ratio : -458.20% (As of Sep. 2024 )

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. China SXT Pharmaceuticals's current 1-Year Share Buyback Ratio was -458.20%.

SXTC's 1-Year Share Buyback Ratio is ranked worse than
98.51% of 537 companies
in the Drug Manufacturers industry
Industry Median: -1.9 vs SXTC: -458.20

Competitive Comparison of China SXT Pharmaceuticals's 1-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

China SXT Pharmaceuticals 1-Year Share Buyback Ratio Calculation

China SXT Pharmaceuticals's 1-Year Share Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Sep. 2023 )	-	Shares Outstanding (EOP) (Sep. 2024 ))	/	Shares Outstanding (EOP) (Sep. 2023 )
	=	(0.091	-	0.508)	/	0.091
	=	-458.2%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals (NAS:SXTC) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

China SXT Pharmaceuticals 1-Year Share Buyback Ratio Related Terms

China SXT Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.